Login
Toggle navigation
Videos
Categories
Trending
A company introduction movie for SAMICK THK CO., LTD., part of the Korean SAMICK THK Group.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Ju-Wan Jin is President/Co-CEO at Samick Thk Co Ltd
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Max Tuesley Provides Update on Culpeo Minerals’ Drilling Progress at Resourcing Tomorrow 2022 | Max Tuesley, Managing Director , Culpeo Mineral Plc.
00:10:00
Revolutionizing Plastic Waste Management: A Sustainable Solution | Niels Stielund, Chairman, Wpu Waste Plastic Upcycling A/S.
00:00:00
Respiri talks Access Telehealth acquisition and US growth - Marjan Mikel Chief Executive Officer, Respiri Ltd
00:10:00
Exploring Healthcare Investment Opportunities in the UK: Insights from Portfolio Analysis and Market Fundamentals|CEO,Aedifica NV
00:10:00
Growth Opportunities in Renewable Energy Amidst Market Trends and Government Support | John Berger, CEO , Sunnova Energy International Inc.
00:00:00
Satyajit T. Reddy, M.D. Cardiologist, Mayo Clinic
00:10:00
Reflections on Leadership: Insights on Bank Regulations, Basel III, and Federal Reserve Policy
00:10:00
Enea partners with Last Energy to develop low-emission SMR reactors in Poland, in line with national energy objectives | Paweł Majewski, CEO, Enea SA.
00:10:00
Last week, SpartanNash CEO Tony Sarsam discussed business insights with CNBC Mad Money, referencing Casella Waste Systems.
00:10:00
Darren Hazelwood on Panther Metals' Breakthrough Graphite Discovery in Ontario's Obonga Greenstone Belt | Darren Hazelwood, CEO, Panther Metals Ltd.
00:10:00
Macquarie Capital: Driving Growth Through Innovation and Collaboration
00:10:00
Ken Fisher, founder of Fisher Investments, advises investors to stay disciplined, diversify, and avoid market timing for long-term success.|Ken Fisher, founder of Fisher Investments